TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
AUTHORS
Glaser
ZA ,
Love
HD ,
Guo
S ,
Gellert
L ,
Chang
SS ,
Herrell
SD ,
Barocas
DA ,
Penson
DF ,
Cookson
MS ,
Clark
PE ,
. Urologic oncology. 2017 1 17; ().
- PMID: 28108243 [PubMed].
ABSTRACT
Our aims were to determine if targeting protein for Xklp2 (TPX2) is correlated with clear cell renal cell carcinoma (ccRCC) histology and oncologic outcomes using The Cancer Genome Atlas (TCGA) and an institutional tissue microarray (TMA).
Our aims were to determine if targeting protein for Xklp2 (TPX2) is correlated with clear cell renal cell carcinoma (ccRCC) histology and oncologic outcomes using The Cancer Genome Atlas (TCGA) and an institutional tissue microarray (TMA).
Tags: Alumni Publications 2017